The Prediction of Preeclampsia/Toxemia in Twin Pregnancy

Preeclampsia/Toxemia Clinical Trial

Official title:

Prospective Longitudenal Study in the Prediction of Preeclampsia/Toxemia in Twin Pregnancy

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01255202
• Other study ID #: 189/09
• Status: Recruiting
• Phase: N/A
• First received: December 5, 2010
• Last updated: December 6, 2010
• Start date: September 2009
• Est. completion date: December 2011

Study information

• Verified date: December 2010
• Source: Assaf-Harofeh Medical Center
• Contact: Ran Svirsky, MD
• Phone: 972-8-9779000
• Email: rsvirs[@]gmail.com
• Is FDA regulated: No
• Health authority: Israel: Ethics Commission
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to finout whetere uterinae artery flow , PP13 and endogolin levels in the serum and kongo red in the urine can predict preeclamsia toxemia in twin pregnancies.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 200
• Est. completion date: December 2011
• Est. primary completion date: April 2011
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

• a women with a vaiable twin pregnany

Exclusion Criteria:

• women with thrombophilya

• women terated with anticoagolant

• women with vascular disease

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Pre-Eclampsia
• Preeclampsia/Toxemia
• Sepsis
• Toxemia

Locations

Country	Name	City	State
Israel	Assaf Harofe Medical Center	Zrifin

Sponsors (1)

Lead Sponsor	Collaborator
Assaf-Harofeh Medical Center

Country where clinical trial is conducted

Israel,